Winter Park, Florida
Alzheimer's disease clinical trials in Winter Park, FL
11 Alzheimer's disease studies are recruiting participants at sites in Winter Park as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Winter Park at a glance
- 11 studies are recruiting at a site in Winter Park.
- By phase: Phase 1/2 (2), Phase 2 (4), Phase 3 (4), Observational (1).
- By sponsor: industry (10), university, hospital or other (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Winter Park
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Conquest Research, LLC
- Registry record
- NCT07177352 · updated
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
- Phase 2
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Conquest Research, LLC
- Registry record
- NCT07781657 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Conquest Research, LLC
- Registry record
- NCT07717411 · updated
Flutemetamol F 18 Injection Formulation Comparison
- Phase 2
- Ages 50 to 110
- All sexes
- Sponsor
- GE Healthcare
- Study site
- Clinical Site Partners, LLC dba Flourish Research
- Registry record
- NCT07873463 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Conquest Research
- Registry record
- NCT07589595 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Conquest Research
- Registry record
- NCT07602582 · updated
[18F]PI-2620 Phase 3 Histopathological Study
- Phase 3
- Ages 50 and older
- All sexes
- Sponsor
- Lantheus Biosciences Ltd.
- Study site
- Charter Research
- Registry record
- NCT05641688 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Conquest Research LLC ( Site 1053)
- Registry record
- NCT07033494 · updated
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Phase 1/2
- Ages 50 to 90
- All sexes
- Sponsor
- AbbVie
- Study site
- Conquest Research - Winter Park /ID# 277760
- Registry record
- NCT07599670 · updated
Low-Dose Radiotherapy for Alzheimer's Disease
- Phase 1/2
- Ages 50 and older
- All sexes
- Sponsor
- Evan Thomas
- Study site
- Renaissance Institute of Precision Oncology & Radiosurgery
- Registry record
- NCT07693140 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Study site
- Conquest Research
- Registry record
- NCT06584357 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Winter Park, FL on ClinicalTrials.gov.
Ask about studies near Winter Park
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections